Researchers are investigating new ways to reduce thromboembolic risks after intracranial stent placement. A study published in May 2026 highlights a dual-therapy approach for accelerating neointima formation. Specifically, scientists aim to minimize the dangerous period before complete endothelialization occurs. They achieve this by combining a vascular endothelial growth factor (VEGF) coating with mesenchymal stem cell (MSC) injections.

The Mechanism for Accelerating Neointima Formation

Furthermore, the experimental model utilized New Zealand White rabbits to test various stent coatings. In addition, researchers applied a poly(lactic-co-glycolic acid) (PLGA) coating embedded with VEGF to endovascular stents. They then supplemented the procedure with an intra-arterial MSC injection immediately after deployment. Consequently, this strategy significantly improved the biological response compared to standard controls.

Moreover, protein quantification confirmed that the VEGF/PLGA coating remained stable during the delivery process. This stability is vital for ensuring that the therapeutic agents reach the vessel wall. Therefore, the combination therapy led to superior measurements in several key metrics after only three days.

Short-Term Results and Clinical Implications

After the initial procedure, optical coherence tomography (OCT) revealed substantial improvements in tissue coverage. The treated group showed a significantly higher neointimal area and a better stent-strut coverage ratio. In addition, scanning electron microscopy (SEM) confirmed improved endothelialization scores. Although the reduction in thrombus formation variability did not reach full statistical significance, the trend suggests a protective effect.

Consequently, this short-term study provides a proof-of-concept for enhancing vascular healing. Speeding up tissue growth over stent struts may drastically lower the incidence of early stroke-related complications. However, the researchers emphasize that follow-up studies must now assess long-term consequences and the exact mechanisms behind this effect.

Frequently Asked Questions

Why is neointima formation important after stenting?

Neointima formation is essential because it creates a biological barrier over the stent. Until this layer forms, the foreign material of the stent remains exposed to blood flow. This exposure significantly increases the risk of thrombus formation and embolic events.

How do MSCs contribute to stent healing?

Mesenchymal stem cells (MSCs) possess unique pro-angiogenic properties. When injected intra-arterially, they migrate to the site of injury. There, they stimulate the recruitment of endothelial cells and promote rapid tissue regeneration and repair.

Are these results applicable to human patients?

While the rabbit model provides promising data, these findings are currently experimental. Clinical application requires further validation through extensive human trials. The study serves as a foundational step toward developing bio-active stents that heal faster.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Panchendrabose K et al. Effect of VEGF coating and intra-arterial injection of mesenchymal stem cells on neointima formation after endovascular stenting in a rabbit model. J Neurosurg. 2026 May 29. doi: 10.3171/2025.12.JNS251651. PMID: 42214099.

Fujii K, et al. Formation and Transformation of Neointima after Drug-eluting Stent Implantation: Insights from Optical Coherence Tomographic Studies. PMC. 2017 Oct 19.

Life Science Daily News. MSC Therapy 2026: iPSC Manufacturing & Clinical Trials. Published February 17, 2026.